{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:43:40Z","timestamp":1786985020932,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R33AG059206"],"award-info":[{"award-number":["R33AG059206"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006441","name":"Center for Outcomes Research and Evaluation, Yale School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006441","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL139985-01A1"],"award-info":[{"award-number":["R01 HL139985-01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL146884-01"],"award-info":[{"award-number":["R01HL146884-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K99CA237744"],"award-info":[{"award-number":["K99CA237744"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005565","name":"Janssen Biotech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005227","name":"Centers for Medicare and Medicaid Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005227","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bbmt.2020.09.013","type":"journal-article","created":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T20:40:52Z","timestamp":1600548052000},"page":"2335-2345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age"],"prefix":"10.1016","volume":"26","author":[{"given":"Colin","family":"Flannelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan E-Xin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian Liang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin M.","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrika","family":"Sanapala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Lagu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane L.","family":"Liesveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Aljitawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason H.","family":"Mendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi D.","family":"Klepin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Stock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya M.","family":"Wildes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Artz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navneet S.","family":"Majhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kah Poh","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2020.09.013_bib0001","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.bbmt.2017.05.035","article-title":"Current use and trends in hematopoietic cell transplantation in the United States","volume":"23","author":"D'Souza","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0002","unstructured":"CIBMTR. Summary slides\u2014HCT trends and survival data. Available at: https:\/\/www.cibmtr.org\/ReferenceCenter\/SlidesReports\/SummarySlides\/pages\/index.aspx#DownloadSummarySlides. Accessed December 7, 2019."},{"key":"10.1016\/j.bbmt.2020.09.013_bib0003","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.bbmt.2013.07.020","article-title":"Prevalence of hematopoietic cell transplant survivors in the United States","volume":"19","author":"Majhail","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0004","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2012.10.005","article-title":"Hematopoietic cell transplantation in 2020: summary of year 2 recommendations of the National Marrow Donor Program's System Capacity Initiative","volume":"19","author":"Denzen","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0005","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bbmt.2011.10.004","article-title":"The National Marrow Donor Program's Symposium on Hematopoietic Cell Transplantation in 2020: a health care resource and infrastructure assessment","volume":"18","author":"Majhail","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0006","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41409-019-0748-1","article-title":"Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults","volume":"55","author":"Majhail","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0007","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.bbmt.2015.03.020","article-title":"National survey of hematopoietic cell transplantation center personnel, infrastructure, and models of care delivery","volume":"21","author":"Majhail","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0008","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1200\/JCO.2007.15.0169","article-title":"Individual physician practice variation in hematopoietic cell transplantation","volume":"26","author":"Lee","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0009","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.bbmt.2014.05.011","article-title":"Financial burden in recipients of allogeneic hematopoietic cell transplantation","volume":"20","author":"Khera","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0010","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41409-018-0164-y","article-title":"Socioeconomic and health system factors associated with lower utilization of hematopoietic cell transplantation in older patients with acute myeloid leukemia","volume":"53","author":"Bhatt","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0011","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/sj.bmt.1702845","article-title":"Non-HLA barriers to unrelated donor stem cell transplantation","volume":"27","author":"Kollman","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0012","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ajh.23753","article-title":"Use of autologous hematopoietic cell transplantation as initial therapy in multiple myeloma and the impact of socio-geo-demographic factors in the era of novel agents","volume":"89","author":"Al-Hamadani","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0013","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.bbmt.2009.12.529","article-title":"Access to hematopoietic cell transplantation in the United States","volume":"16","author":"Majhail","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126709","article-title":"Characteristics of randomized controlled trials designed for elderly: a systematic review","volume":"10","author":"Broekhuizen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/2040620716643493","article-title":"Reduced-intensity conditioning allogeneic hematopoietic-cell transplantation for older patients with acute myeloid leukemia","volume":"7","author":"Goyal","year":"2016","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0016","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0017","unstructured":"Kmet, L, Lee R, Cook, L. Standard quality assessment criteria for evaluating primary research papers from a variety of fields. 2004. Available at: http:\/\/www.ihe.ca\/documents\/HTA-FR13.pdf. Accessed December 26, 2019."},{"key":"10.1016\/j.bbmt.2020.09.013_bib0018","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1016\/j.bbmt.2019.02.004","article-title":"Barriers to allogeneic hematopoietic stem cell transplantation for human T cell lymphotropic virus 1-associated adult T cell lymphoma-leukemia in the United States: experience from a large cohort in a major tertiary center","volume":"25","author":"Adrianzen Herrera","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0019","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.bbmt.2010.08.011","article-title":"Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities","volume":"16","author":"Barker","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0020","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.leukres.2011.10.018","article-title":"Racial differences in presentation, referral and treatment patterns and survival in adult patients with acute myeloid leukemia: a single-institution experience","volume":"36","author":"Bierenbaum","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0021","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.bbmt.2014.12.024","article-title":"Disparities in utilization of autologous hematopoietic cell transplantation for treatment of multiple myeloma","volume":"21","author":"Costa","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0022","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/bmt.2015.246","article-title":"Geographic access to hematopoietic cell transplantation services in the United States","volume":"51","author":"Delamater","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0023","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/cncr.30526","article-title":"Racial disparities in treatment use for multiple myeloma","volume":"123","author":"Fiala","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0024","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbmt.2017.03.020","article-title":"Allogeneic hematopoietic stem cell transplantation is underutilized in older patients with myelodysplastic syndromes","volume":"23","author":"Getta","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174760","article-title":"Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients","volume":"12","author":"Jabo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0026","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1002\/cncr.25297","article-title":"Access to hematopoietic stem cell transplantation: effect of race and sex","volume":"116","author":"Joshua","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0027","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/1475-6773.12208","article-title":"Factors affecting receipt of expensive cancer treatments and mortality: evidence from stem cell transplantation for leukemia and lymphoma","volume":"50","author":"Mitchell","year":"2015","journal-title":"Health Serv Res"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0028","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1158\/1055-9965.EPI-14-0963","article-title":"How do differences in treatment impact racial and ethnic disparities in acute myeloid leukemia?","volume":"24","author":"Patel","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0029","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.bbmt.2019.06.012","article-title":"Inferior access to allogeneic transplant in disadvantaged populations: a Center for International Blood and Marrow Transplant Research Analysis","volume":"25","author":"Paulson","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0030","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/bmt.2012.150","article-title":"Race\/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization","volume":"48","author":"Pidala","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0031","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/bmt.2012.95","article-title":"Practice variation in physician referral for allogeneic hematopoietic cell transplantation","volume":"48","author":"Pidala","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0032","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1200\/JOP.2013.001155","article-title":"Variation in Medicaid coverage for hematopoietic cell transplantation","volume":"10","author":"Preussler","year":"2014","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0033","first-page":"1167","article-title":"Patient housing barriers to hematopoietic cell transplantation: results from a mixed-methods study of transplant center social workers","volume":"24","author":"Preussler","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0034","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3324\/haematol.2012.063602","article-title":"Recent trends in survival of adult patients with acute leukemia: overall improvements, but persistent and partly increasing disparity in survival of patients from minority groups","volume":"98","author":"Pulte","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0035","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1002\/cncr.30747","article-title":"Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: a CIBMTR report","volume":"123","author":"Schriber","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0036","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/ajh.10273","article-title":"Access to stem cell transplantation: do women fare as well as men?","volume":"72","author":"Mehta","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0037","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1056\/NEJM199201163260303","article-title":"Reasons that patients with acute myelogenous leukemia do not undergo allogeneic bone marrow transplantation","volume":"326","author":"Berman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0038","series-title":"Factors Affecting Stem Cell Transplantation for Leukemia and Lymphoma","author":"Cho","year":"2006"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0039","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/cncr.20628","article-title":"Hematopoietic stem cell transplantation among patients with leukemia of all ages in Texas","volume":"101","author":"Hwang","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0040","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1200\/JCO.1997.15.7.2644","article-title":"Access to bone marrow transplantation for leukemia and lymphoma: the role of sociodemographic factors","volume":"15","author":"Mitchell","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0041","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bbmt.2015.10.019","article-title":"Outcomes of allogeneic stem cell transplantation in elderly patients with acute myeloid leukemia: a systematic review and meta-analysis","volume":"22","author":"Rashidi","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0042","doi-asserted-by":"crossref","first-page":"e427","DOI":"10.1016\/S2352-3026(15)00148-9","article-title":"Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis","volume":"2","author":"Versluis","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0043","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1182\/blood-2017-03-772368","article-title":"Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States","volume":"130","author":"Muffly","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0044","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1200\/JCO.2009.25.4821","article-title":"Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome","volume":"28","author":"McClune","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0045","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1038\/s41375-019-0477-x","article-title":"Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study","volume":"33","author":"Ustun","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0046","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1200\/JCO.2015.62.7273","volume":"33","author":"Devine","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0047","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ajh.24575","article-title":"Reduced intensity conditioned allograft yields favorable survival for older adults with B-cell acute lymphoblastic leukemia","volume":"92","author":"Rosko","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0048","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1182\/blood.V126.23.193.193","article-title":"Outcome of patients 65 years and older with myelodysplastic syndrome (MDS) receiving allogeneic hematopoietic stem cell transplantation compared to patients 55-64 years of age","volume":"126","author":"Atallah","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0049","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1182\/bloodadvances.2020001719","article-title":"Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes","volume":"4","author":"Olin","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jgo.2019.09.012","article-title":"Use of geriatric assessment in hematopoietic cell transplant","volume":"11","author":"Jayani","year":"2020","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0051","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3324\/haematol.2014.103655","article-title":"Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients","volume":"99","author":"Muffly","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0052","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1182\/bloodadvances.2019000790","article-title":"Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults","volume":"3","author":"Derman","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0053","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/bmt.2011.214","article-title":"Racial disparities in hematopoietic cell transplantation in the United States","volume":"47","author":"Majhail","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0054","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-publhealth-032315-021439","article-title":"Racial and ethnic disparities in the quality of health care","volume":"37","author":"Fiscella","year":"2016","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0055","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1182\/bloodadvances.2018021899","article-title":"Is a matched unrelated donor search needed for all allogeneic transplant candidates?","volume":"2","author":"Ciurea","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0056","first-page":"1117","article-title":"How generalizable are the SEER registries to the cancer populations of the USA?","volume":"27","author":"Kuo","year":"2016","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0057","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.bbmt.2010.08.011","article-title":"Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities","volume":"16","author":"Barker","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0058","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1001\/jamaoncol.2016.6905","article-title":"Using the National Cancer Database for outcomes research: a review","volume":"3","author":"Boffa","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.bbmt.2020.09.013_bib0059","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/bmt.2008.101","article-title":"The role of registries in facilitating clinical research in BMT: examples from the Center for International Blood and Marrow Transplant Research","volume":"42","author":"Horowitz","year":"2008","journal-title":"Bone Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879120305851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879120305851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:12:56Z","timestamp":1761059576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879120305851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":59,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1083879120305851"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2020.09.013","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2020.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}